Horizon Pharma, Gruenenthal sales and marketing update

Horizon granted Gruenenthal exclusive rights in Latin America to commercialize Duexis ibuprofen/famotidine. Horizon will receive an undisclosed upfront payment and is eligible for milestones and roya...